| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Issuance costs for shares issued under 2024 equity private placement | - | 6,514 |
| Net cash (used in) provided by financing activities | -2,255 | -2,296 |
| Net decrease in cash and cash equivalents | -104,220 | -87,007 |
| Cash and cash equivalents at beginning of period | 139,480 | - |
| Cash and cash equivalents at end of period | 35,260 | - |
Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA)